Introduction: What is Obinutuzumab?
Obinutuzumab is a monoclonal antibody used in the treatment of certain types of cancer, particularly chronic lymphocytic leukemia (CLL) and some forms of nonHodgkin lymphoma (NHL). It is designed to target and destroy specific cancer cells by marking them for the immune system to recognize and attack. Obinutuzumab is often used in combination with other therapies to enhance its effectiveness.
Uses of Obinutuzumab
Obinutuzumab is primarily approved for the following medical uses: